Endovascular therapy for long-segment atherosclerotic aortoiliac occlusion
Liangxi Yuan1, Junmin Bao1, Zhiqing Zhao1
1Department of Vascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Insights
Endovascular therapy, including stenting and catheter-directed thrombolysis (CDT), is a feasible treatment for long-segment aortoiliac occlusion. This approach demonstrated high technical success and favorable midterm patency with low complication rates.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Interventions
Background:
- Long-segment atherosclerotic aortoiliac occlusion poses a significant challenge in vascular treatment.
- Endovascular therapy offers a less invasive alternative to traditional surgical methods.
Purpose of the Study:
- To investigate the outcomes of endovascular therapy for long-segment atherosclerotic aortoiliac occlusion.
- To evaluate the technical success, complication rates, and midterm patency of these interventions.
Main Methods:
- Retrospective analysis of 20 patients with long-segment aortoiliac occlusion (>10 mm) treated between May 2008 and January 2013.
- Procedures included stent implantation, with or without catheter-directed thrombolysis (CDT), percutaneous transluminal angioplasty (PTA), and stenting via brachial or femoral artery puncture.
Main Results:
- Technical success rate was 95% (19 of 20 patients).
- No in-hospital mortality was observed; one patient experienced retroperitoneal hemorrhage.
- Significant improvement in postoperative ankle-brachial indexes and clinical Rutherford categories was noted.
- Primary patency rates were 93.3% at 6 months, 83% at 18 months, and 66.4% at 24 months.
Conclusions:
- Endovascular therapy is a feasible option for complete long-segment infrarenal aortic occlusion.
- The combined approach of PTA, stenting, and CDT offers lower complication rates.
- Favorable midterm patency rates support the use of endovascular interventions in selected patients.
Objective:
This retrospective nonrandomized study investigated the outcomes of endovascular therapy for long-segment atherosclerotic aortoiliac occlusion.
Methods:
From May 2008 to January 2013, 20 patients (one woman and 19 men; mean age, 66.1 years; range, 43-89 years) underwent stent implantation, with or without catheter-directed thrombolysis (CDT), for long-segment aortoiliac occlusion (>10 mm).
Results:
The technical success rate was 95% (19 of 20). No in-hospital mortality was recorded. Aortic thrombus was successfully eliminated with CDT in four patients before percutaneous transluminal angioplasty (PTA) and stenting. Retroperitoneal hemorrhage occurred in one patient, who refused further endovascular surgery. Another 15 patients were treated with PTA and stenting. Postoperative ankle-brachial indexes increased significantly from preoperative values (P < .05). Seventeen patients showed clinical improvement from baseline by an average of 2.5 Rutherford categories. The mean follow-up interval was 17.6 months (range, 4-39 months). The primary patency rates were 93.3% ± 6.4% at 6 months, 83% ± 11.3% at 18 months, and 66.4% ± 17.4% at 24 months.
Conclusions:
Through brachial and femoral artery puncture, PTA, stenting, and CDT, endovascular therapy is feasible for complete long-segment infrarenal aortic occlusion, with lower complication rates and favorable midterm patency.
Related Concept Videos
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Atherosclerosis III: Management

